Stroke News and Research

RSS
A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.
Study of diabetes prevention programmes suggests need for more implementation of NICE guidance

Study of diabetes prevention programmes suggests need for more implementation of NICE guidance

Patients' risk of stroke increases following shingles, but antiviral drugs appear to offer protection

Patients' risk of stroke increases following shingles, but antiviral drugs appear to offer protection

Young adults participated in cardio fitness activities may preserve memory, thinking skills in middle age

Young adults participated in cardio fitness activities may preserve memory, thinking skills in middle age

New clinic that focuses on diagnosis and treatment for vertigo launched in Mumbai

New clinic that focuses on diagnosis and treatment for vertigo launched in Mumbai

Leading researchers to convene at 4th Annual Traumatic Brain Injury Conference

Leading researchers to convene at 4th Annual Traumatic Brain Injury Conference

Study shows important parallels between epidemic of HIV/AIDS and opioid addiction

Study shows important parallels between epidemic of HIV/AIDS and opioid addiction

Boston Scientific presents new data on cardiology-related clinical trials at ACC 2014

Boston Scientific presents new data on cardiology-related clinical trials at ACC 2014

Scientists discover how MRP-14 gene generates dangerous clots that could trigger heart attack

Scientists discover how MRP-14 gene generates dangerous clots that could trigger heart attack

Northwestern University awarded NIH grant to conduct phase III Parkinson's neuroprotective study

Northwestern University awarded NIH grant to conduct phase III Parkinson's neuroprotective study

Researchers identify possible mechanism for re-growing damaged nerve fibres in central nervous system

Researchers identify possible mechanism for re-growing damaged nerve fibres in central nervous system

Research uncovers link between diet and blood cell markers of heart attack associated inflammation

Research uncovers link between diet and blood cell markers of heart attack associated inflammation

Clonidine increases hypotension and non-fatal cardiac arrest after noncardiac surgery

Clonidine increases hypotension and non-fatal cardiac arrest after noncardiac surgery

Sodium pump plays vital role in nerve impulses, heartbeats and muscular contraction

Sodium pump plays vital role in nerve impulses, heartbeats and muscular contraction

Heparin proves effective than bivalirudin in patients receiving percutaneous coronary intervention after heart attack

Heparin proves effective than bivalirudin in patients receiving percutaneous coronary intervention after heart attack

Study shows administering steroids during cardiac surgery requiring bypass can cause harm

Study shows administering steroids during cardiac surgery requiring bypass can cause harm

UT Southwestern launches telemedicine program to extend stroke care to patients in rural areas

UT Southwestern launches telemedicine program to extend stroke care to patients in rural areas

Bariatric surgery more effective than intensive medical therapy for managing type 2 diabetes

Bariatric surgery more effective than intensive medical therapy for managing type 2 diabetes

S. pneumoniae is commonest cause of paediatric CAP

S. pneumoniae is commonest cause of paediatric CAP

Rigorous blood pressure control could halve recurrent stroke risk

Rigorous blood pressure control could halve recurrent stroke risk

rEVO Biologics commences ATryn Phase 3 clinical program for treatment of preeclampsia in pregnant women

rEVO Biologics commences ATryn Phase 3 clinical program for treatment of preeclampsia in pregnant women

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.